Alembic Global Advisors is an independent equity research firm offering differentiated, experienced financial analysis on a variety of global industrial sectors. Our goal is to provide high quality, proprietary and actionable research into company, industry and broader macro trends on a truly global level.
Since its founding in 2009, Alembic has expanded from its core global chemical coverage to the aerospace & defense sector. Our analysts have been recognized by industry publications Institutional Investor, FT/Starmine and Extel.2 research analysts covering 35 companies across 3 industries (Chemicals and Aerospace & Defense). Our coverage list continues to grow as we remain focused on delivering our best-in-class research product.
Through our corporate access events we provide unique opportunities to meet with a select group of industry leaders, offering the chance to gain unique insights from people operating at the highest levels of their respective industries.
In addition to highly analytical deep dive research surrounding our specific equity coverage, we provide our macro view of each industry against the global backdrop of current events and how we see them shaping the future. We leverage our various areas of expertise to produce a collaborative cross-sector research product. This non-siloed approach allows us to maximize our areas of expertise, ultimately achieving a more dynamic and in-depth level of insight.
Not a client? Please contact Stephen Matthews – stephen.matthews@alembicglobal.com – to learn more about our research subscription offerings.
Access is limited to Alembic Global Advisors clients.
Key Points We are modestly raising our top- and bottom-line forecast for RTX post yesterday’s 1Q26 earnings call, and we’re reiterating our Overweight rating on the shares. We’re maintaining our ......
Key Points Recovery may extend well beyond initial expectations as widespread plant damage and limited access to critical equipment may delay restarts across the Middle East Tight availability of naphtha, ......
Key Points We are terminating coverage of Textron Inc. (TXT; previously rated Neutral) due to a change in research focus. Going forward, we will no longer maintain an investment rating ......
Key Points We’re updating our outlook for GD for the first time post the firm’s 4Q earnings results, and we’re maintaining our Neutral rating on the shares. Our target price ......
Key Points Q1 stronger than feared, but already priced in: Solid volumes and PE margin expansion offset ethylene weakness; consensus broadly captures y-o-y earnings decline Earnings upside underappreciated: Product price ......
Key Points We’re updating our outlook for BA after yesterday’s release of 1Q26 orders and deliveries data. We’re making minimal changes to our forecast but our target price declines USD13 ......